CORRINE MILLER: Open Payments
NPI 1669225215 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 78 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $555 · 2025 $1,892
Food & beverage: $1,792Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $469 |
| GlaxoSmithKline, LLC. | 13 | $214 |
| Regeneron Healthcare Solutions, Inc. | 8 | $181 |
| United Therapeutics Corporation | 5 | $144 |
| JAZZ PHARMACEUTICALS INC. | 5 | $128 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Verona Pharma, Inc. | 3 | $58 |
| Viatris Specialty LLC | 3 | $55 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, Tyvaso, XYWAV, NUCALA, TRELEGY ELLIPTA, GLASSIA.
Industry payments across IN — which companies pay providers there.
